Literature DB >> 15713606

Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad.

Ramanuj Lahiri1, Baljit Randhawa1, James Krahenbuhl1.   

Abstract

Mycobacterium leprae cannot be cultured, so ascertaining viability of the organism remains a major obstacle, impeding many avenues of investigation. This study tested a two-colour, Syto9 and propidium iodide, fluorescence assay, which scores for membrane damage in individual bacilli, to determine if a rapid direct-count viability-staining technique can be reliably applied to M. leprae. A variety of experimental conditions were employed to validate this technique. This technique was also used to correlate the viability of M. leprae with the course of athymic mouse foot pad infection to optimize the provision of viable M. leprae as a research reagent. The data show that in untreated suspensions of M. leprae there is a good correlation between the metabolic activity of leprosy bacilli and their membrane damage. Fixation of M. leprae with ethanol, paraformaldehyde and gluteraldehyde completely suppressed their metabolic activity but showed little effect on their membrane integrity. The present study also showed that the metabolic activity of M. leprae declines more than the extent of membrane damage at 37 degrees C within 72 h, but that they are not significantly affected at 33 degrees C. Irradiation at 10(4) Gy showed high numbers of dead bacilli by the staining method. The results show that the reliability of metabolic-activity data as well as viability-staining data is dependent on the method by which M. leprae is killed. This staining method helped us predict reliably that the smaller M. leprae-infected athymic mouse foot pad seen early in infection, between 4 and 5 months, yields markedly better quality leprosy bacilli than older, larger foot pad infections, as defined by their metabolic activity and membrane integrity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713606     DOI: 10.1099/jmm.0.45700-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  38 in total

1.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

2.  Murine experimental leprosy: Evaluation of immune response by analysis of peritoneal lavage cells and footpad histopathology.

Authors:  Fátima Regina Vilani-Moreno; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Suzana Madeira Diório; Sônia Maria Usó Ruiz Silva; Patrícia Sammarco Rosa; Andréa de Faria Fernandes Belone; Cleverson Teixeira Soares; José Roberto Pereira Lauris; Sílvia Cristina Barboza Pedrini
Journal:  Int J Exp Pathol       Date:  2019-05-24       Impact factor: 1.925

3.  Real-time microsensor measurement of local metabolic activities in ex vivo dental biofilms exposed to sucrose and treated with chlorhexidine.

Authors:  Christiane von Ohle; Armin Gieseke; Laura Nistico; Eva Maria Decker; Dirk DeBeer; Paul Stoodley
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

4.  Live Mycobacterium leprae inhibits autophagy and apoptosis of infected macrophages and prevents engulfment of host cell by phagocytes.

Authors:  Yuelong Ma; Qin Pei; Li Zhang; Jie Lu; Tiejun Shui; Jia Chen; Chao Shi; Jun Yang; Michael Smith; Yeqiang Liu; Jianyu Zhu; Degang Yang
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

5.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

6.  Mycobacterium leprae upregulates IRGM expression in monocytes and monocyte-derived macrophages.

Authors:  Degang Yang; Jia Chen; Linglin Zhang; Zhanshan Cha; Song Han; Weiwei Shi; Ru Ding; Lan Ma; Hong Xiao; Chao Shi; Zhichun Jing; Ningjing Song
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

7.  Interaction of Mycobacterium leprae with human airway epithelial cells: adherence, entry, survival, and identification of potential adhesins by surface proteome analysis.

Authors:  Carlos A M Silva; Lia Danelishvili; Michael McNamara; Márcia Berredo-Pinho; Robert Bildfell; Franck Biet; Luciana S Rodrigues; Albanita V Oliveira; Luiz E Bermudez; Maria C V Pessolani
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

8.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

9.  Molecular determination of Mycobacterium leprae viability by use of real-time PCR.

Authors:  Alejandra N Martinez; Ramanuj Lahiri; Tana L Pittman; David Scollard; Richard Truman; Milton O Moraes; Diana L Williams
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

10.  Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy.

Authors:  P-Y Bochud; D Sinsimer; A Aderem; M R Siddiqui; P Saunderson; S Britton; I Abraham; A Tadesse Argaw; M Janer; T R Hawn; G Kaplan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.